SCHEMBL26418832

SCHEMBL26418832

CO/C=C(\Oc1cccc(C(=O)c2ccccc2)c1)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
STS P08842 4/20 0.46
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SRD5A2 P31213 1/20 0.42
ELANE P08246 3/20 0.42
VNN1 O95497 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MTNR1B P49286 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
HTT P42858 1/20 0.40
KCNK3 O14649 1/20 0.40
KCNK9 Q9NPC2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8026283 0.86 NPC1 (0.48) MEN1KMT2AL3MBTL1NPC1RAB9A
SCHEMBL8026280 0.86 NPC1 (0.48) MEN1KMT2AL3MBTL1NPC1RAB9A
SCHEMBL10760573 0.83 EPHX1 (0.46)
SCHEMBL8022465 0.82 NPC1 (0.42) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7695019 0.80 LMNA (0.54) MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7695017 0.80 LMNA (0.54) MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL10762565 0.80 MTNR1A (0.42) MEN1KMT2ANPC1MTNR1BALDH1A1
SCHEMBL8026084 0.78 PPARG (0.48) L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL23796701 0.77 TRPV1 (0.41) ATML3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL21902146 0.77 TUBB4A (0.43) TDP1L3MBTL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127143-A1 METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127143-A1 METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE CYC1, COX5B, SQOR MEN1 2799/4885KMT2A 2647/4885STS 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.